GB1588533A - Phenylamidine derivatives - Google Patents

Phenylamidine derivatives Download PDF

Info

Publication number
GB1588533A
GB1588533A GB1670577A GB1670577A GB1588533A GB 1588533 A GB1588533 A GB 1588533A GB 1670577 A GB1670577 A GB 1670577A GB 1670577 A GB1670577 A GB 1670577A GB 1588533 A GB1588533 A GB 1588533A
Authority
GB
United Kingdom
Prior art keywords
acid
solution
mol
water
acetamidoxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1670577A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to GB1670577A priority Critical patent/GB1588533A/en
Priority to CH118978A priority patent/CH630606A5/en
Priority to DE19782804576 priority patent/DE2804576A1/en
Priority to ES466887A priority patent/ES466887A2/en
Priority to CA296,767A priority patent/CA1133920A/en
Priority to FR7804019A priority patent/FR2380256A2/en
Priority to BE185158A priority patent/BE863947R/en
Priority to IT67297/78A priority patent/IT1156441B/en
Priority to JP1639078A priority patent/JPS53103430A/en
Priority to US06/107,609 priority patent/US4325964A/en
Publication of GB1588533A publication Critical patent/GB1588533A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56Radicals substituted by sulfur atoms

Description

(54) PHENYLAMIDINE DERIVATIVES (71) We, LABORATOIRE L. LAFON, a French Body Corporate of 1, Rue Georges Mederic, 94700 Maisons-Alfort, France, do hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:- The present invention relates to new phenylamidine derivatives which are useful in therapy.
The main Patent, No. 1,538,097, describes and claims 15 compounds in free base form and their addition salts, which compounds are useful, for example, in therapy. They fall within the general class of substituted phenylamidines of the general formula:
in which: A represents a -CR2-, -CHOR-, -CH2S-, -CH2NH-, -OCR2-, -NH-, -NHCOCH2-, -CH2NHCH2-, or -NHCH2- group, X, represents chlorine or fluorine atom or a methyl methoxy or ethoxy group, X2 represents a hydrogen or chlorine atom, or a methyl, methoxy or ethoxy group and, Z represents a 2-pyrimidinyl group or a group
(where R1 represents H, R2 represents OH or CH2CO2C2Hs, or Rl and R2, considered together, form a -CR2CR2- or -N=N- group), and their addition salts.
According to the invention, there are now proposed, as new products which are useful in therapy, 24 compounds in free base form and their acid addition salts.
These compounds fall within the general class of compounds having the formula
in which: Ar represents an a-naphthyl group, an unsubstituted phenyl group or a phenyl group substituted by one or two methyl, methoxy methylenedioxy, bromine, chlorine, fluorine or nitro groups, and either A represents a -CR2-S- group, B represents a single bond or a methylene (-CR2-) group and Y is an oxygen atom, or A represents an -NHCR2- or -NHCOCR2- group (reading the formula from left to right), B represents a single bond and Y represents an NH group; and their salts.
The term "salts" is herein understood to mean, (i) addition salts of inorganic or organic acids when Y is NH, and (II) metal salts, when Y is O.
The compounds according to the invention are the compounds of formula (I) above in which Ar, A, B and Y have the combinations of meanings set out in Table I below and the salts of these compounds. (The salts are, of course not limited to those mentioned in Table I). The corresponding names of the compounds of the invention are set out in claims 1 to 24 hereof.
TABLE I
Try Code No. Ar A a Ô Melting point I (a) CRL 40514 H3 NHCH2 single bond NH tD r((Y rCI J V) U) a2u, M O ar re 2 (a) i 40527 NHCH2 single bond NH i Br 3 CRL 40531 NHCH2 single bond NH a:840c i (a) CRL 40522 i NHCOL single bond NH x C1 4 E m CRL 4o41o CH2S CH2 NH e N ES g i i i i tz . fs es H o u un u u} < X 4 o < < o g 4 4 - a a c) g P P g Z 4 H N < e TABLE I (continuation 1)
4 : .1 C > o o o Oh O O U PO O o o o H Code No. Ar A H H Melting Point - --- b Sco o Oi00 I 1 m tc ú iB 8 Cl U 9 CR1. 40475A a-naphthyl CH2S CH2 0 129-1300c 10 m 405llA CH2S CH2 e fS fS N fS xU 8 x xU B Q f At Q t f X H TABLE I (continuation 2)
o tr o Oo\ ego Code No. Ar A ri Y Melting IP( ci o o o P) cu cu h) CY CR1. 40516A CN2S CH2 0 l240C m a m m 14 CRL 40539A N CH2S CH2 N llS-1190c < Q fu SuSH Q u u zN z X H vo o 8 s < o q e H N w 2 H H. H TABLE I (continuation 3)
o p b cu h, o rcC o ore I a, rcO c ce > O O IP (Y 2 127-2B0C 3E 16 CR1. B CR30 t te Z j we 30 3 3 U d &commat; t TABLE I (continuation 4)
I Loo Code No. o o o o Melting point Cf ru O 0 r( Q) m l7(a) CRL 40492 H; NHCH2 single bond NH l840C(b) > CRL 40427 NHCH2 single bond NH 1340C 19(d) CRL 40457 C3 NHCH2 single bond NH 1720c g CRL 40477 X NHCH2 single bond g 1500C E C C C E 0 0 0 0 0 9 P A 9 > CRL 40478 NHCH2 single bond NH 1700C C L: C C C m io a m m N ES fS : N E x i i < mUm Ct 9 A WN F b rs O 08 UN b b Z q st w w w e 0q q q 0 q0 P 6 6 g X 6 e F O H X ~I ~ ~4 N 61 TABLE I (continuation 5)
I E Code No. Ar A B y Melting point 22(d) CRL 40482 CH3O NHCH2 single bond NH 1540C 23(d) CRL 40483 H3 NHCH2 single bond NH 136'C to 40487 o NHCH2 single bond to 170C cb) m n n &commat; &commat; &commat; > b b rl d Ul Ul 0a CS N < f mM HOb oX U N b Z q w Ú S S e g e Z X N a3 Notes (a) hydrochloride (b) with decomposition (c) the corresponding hydrochloride melts at 174 - 176 C with decomposition (d) dihydrochloride The compounds of the present invention can be prepared by a method which is in itself known. The recommended methods are those described in the main Patent.
Thus, derivatives of the "hydroxamic acid" type (Y=O) can be prepared according to the method I which is shown schematically by the reaction
(where Ar, A and B are defined as above, and Zl represents Cl, Br, CH3O, C2HsO, n-C3H70 or i-C3R7O).
Derivatives of the "amidoxime" type (Y=NH) can be prepared according to method II or method III which consist, respectively, of reacting a cyano derivative or an iminoalkyl ether derivative with hydroxylamine, according to the reactions
(where Alk represents a C1-C4-alkyl group and Ar, A and B are defined as above).
In general terms the hydroxamic acids and amidoximes of the invention can be prepared according to the reaction
where Z represents COZ1, CN or C(=NH)O-Alk.
The compounds II can be prepared according to a method which is in itself known, for example according to either of methods A and B described in the main Patent.
The compounds of the formula I and their non-toxic salts are useful in therapy.
They act on the central nervous system as sedatives, anxiolytic agents and muscular relaxants. In addition, certain of the compounds exhibit a hypotensive effect.
According to the invention, therapeutic compositions are recommended which contain at least one compound of the invention in association with a physiologically acceptable excipient.
Other advantages and characteristics of the invention will be better understood on reading the preparation Examples which are described below by way of illustration.
EXAMPLE 1 2-(2-Methyl-anilino)-acetamidoxime hydrochloride
Code No.: CRL 40,514 This product is obtained with a yield of 27% according to the following reaction mechanism
Melting point 1620C (with decoinposition) Measure % Cl-: 16.93% Theoretical % Cl-: 16.47% The purity is controlled by thin layer chromatography [eluant:benzene:acetone:NH4OH (30:70:2 v/v); plate:silica gel ("Merck" F 254); development:U.V.+Draggendorf reagent]; "Merck" is a Registered Trade Mark.
EXAMPLE 2 2-(4-Fluoro-anilino)-acetamidoxime hydrochloride
Code No.: CRL 40,527 On proceeding as indicated in Example 1, but replacing the 2-methyl-aniline by 4-fluoro-aniline, the stated product is obtained with a yield of l6Vc.
Melting point: 155-1600C (with decomposition) Measured Vo Cl-: 16.61% Theoretical % C-: 16.17% The purity is controlled by thin layer chromatography, as indicated in Example 1.
EXAMPLE 3 2-(2-Bromo-anilino)-acetamidoxime hydrochloride
Code No.: CRL 40,531 On proceeding as indicated in Example 1, but replacing the 2-methyl-aniline by 2-bromo-aniline, the stated product is obtained with a yield of 13%.
Melting point: 1840C Measured % Cl-: 12.47% Theoretical % Cl-: 12.65% The purity is controlled by thin layer chromatography, as indicated in Example 1.
EXAMPLE 4 2-(3 ,4-Dichloro-anilido)-acetamidoxime hydrochloride
Code No.: CRL 40,522 1) N-Chloroacetyl-3 ,4-dichloraniline 81 g (0.5 mol) of 3,4-dichloroaniline are dissolved 500 ml of acetone. 85 g (0.75 mol) of chloroacetyl chloride are poured in, over a period of 17 minutes, with stirring. The mixture is heated under reflux for 15 minutes, cooled and 350 ml of a 30% strength potassium carbonate solution in water (pH=8) are poured in. This solution is poured into a 2,000 ml Erlenmeyer flask and 500 ml of H2O+ice are added. The precipitate which appears is filtered off, washed with water, dried and recrystallised from benzene. 102 g (yield 85%) of N - chloroacetyl - 3,4 dichloroaniline are thus obtained.
2) N-cyanoacetyl-3,4-dichloroaniline 14.5 g (0.223 mol) of potassium cyanide are dissolved in 122 ml of H2O. 48.50 g (0.203 mol) of the above product, dissolved in 357 ml of 95% strength ethanol, are added (dropwise over a period of 1 hour). The mixture is left stirring, at ambient temperature (15--250C). overnight. The matter which is insoluble in the reaction mixture is filtered off and washed with water and with chloroform. The nitrile which is thus obtained (weight 22.2 g; yield 48%) is used in this state for the continuation of the synthesis.
The purity of the N - cyanoacetyl - 3,4 - dichloroaniline can be controlled by thin layer chromatography [eluant:benzene:ethanol (9:1 v/v); plate:silica gel (Merck F 254); U.V. development].
3) CRL 40,522 A solution of 0.3 mol of hydroxylamine base in methanol is mixed with a solution of 22.2 g (0.096 mol) of the above nitrile in methanol. The reaction mixture is left at ambient temperature overnight. The medium is rendered acid with concentrated hydrochloric acid and 200 ml of H2O are added. The methanol is evaporated off in vacuo. The residual aqueous phase is filtered and neutralised with K2CO3 to an alkaline pH. The neutralised aqueous phase is extracted with ether and the ether solution washed with water and dried over MgSO4 in the presence of charcoal (3SA). The ether solution is filtered and the hydrochloride is precipitated by means of a solution of hydrogen chloride in ethanol. 5 g of CRL 40,522 are thus obtained.
Melting point: 195"C (with decomposition) Yield: 17% Measured % Cl-: 11.41 Theoretical % C1-: 11.89%.
The purity can be controlled, as indicated in Example I, by thin layer chromatography.
EXAMPLE 5 2-(4-Chlorobenzylmercapto)-acetamidoxime
Code No.
1) 4-Chlorobenzylmercapto-acetonitrile 13 ml (15.9 g; 0.1 mol) of 4-chlorobenzylmercaptan and a solution of 4.2 g (0.105 mol) of NaOH in 50 ml of water are mixed whilst cold. Thereafter the mixture is heated to about 60"C and then 7.5 ml (about 1.2 mols) of chloroacetonitrile are added dropwise at this temperature. At the end of this addition (the temperature is then about 80"C) the mixture is heated under reflux (100"C) for 30 to 45 minutes. After cooling, the oil which has formed is extracted with ether and the aqueous phase is discarded. The ether solution is washed with dilute NaOH and then with water until the wash waters have a neutral pH. The ether phase is dried over MgSO4 which is filtered off before the ether is evaporated.
19.7 g of the stated product are collected (yield about 100%, relative to the starting 4-chlorobenzylmercaptan); it is in the form of an oil.
2) 2-(4-Chlorobenzylmercaptan)-acetamidoxime hydrochloride The above product (about 0.1 mol) is taken up in 100 ml of n-butanol and the solution is mixed, whilst cold, with an aqueous solution (50 ml) of 0.2 mol (14 g) of hydroxylamine. The whole is heated at the reflux temperature of the nbutanol/water mixture, with vigorous stirring, for from 2 hours 30 minutes to 3 hours. Thereafter the butanol/water mixture is evaporated and the residue is taken up in water; the base (4-chlorobenzylmercaptoacetamidoxime) crystallises; the mixture is allowed to stand for several hours at 5--100C and then the base is filtered off and dried. 19.6 g of the said base (instantaneous melting point 76"C; yield 85%) are thus collected. The hydrochloride is prepared by dissolving the base in ether and adding a solution of hydrogen chloride in ethanol. After filtration and drying in vacuo, 21 g of the expected product are collected.
Instantaneous melting point: 174--176"C (with decomposition) Yield: 78.5%.
EXAMPLE 6 2-(4-Chlorobenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) Anhydrous acetone (100 ml), potassium carbonate (21 g), pchlorobenzylmercaptan (19.5 ml), methyl chloroacetate (13.2 ml) and potassium iodide (0.1 g) are mixed whilst cold. The mixture which is thus obtained is stirred and heated under reflux for 7 hours. It is then cooled, the precipitate (K2CO3) is filtered off, the acetone is evaporated from the filtrate and the residue is taken up in ether. The ether solution is washed with 4N NaOH and then with water until the wash waters have a neutral pH. It is then dried over MgSO4, the ether is evaporated off and 34.5 g (yield 100%) of methyl 2 - (4 - chlorobenzylmercapto) - acetate are collected in the form of a chromatographically pure oil.
2) A solution of 0.15 mol of methyl 2 - (4 - chlorobenzylmercapto) - acetate in 50 ml of methanol is mixed with a solution of 0.225 mol of hydroxylamine (base) and 0.15 mol of NaOCH3 in 150 ml of methanol.
The resulting mixture is kept overnight at ambient temperature (15-250C), the methanol is evaporated off and the residue is taken up in water and acidified with 3N HCI in order to precipitate 2- (4- chlorobenzylmercapto) acetohydroxamic acid. 31.7 g of the said acid are collected.
Yield 91%: melting point about 1300C.
EXAMPLE 7 2-(3,4-Dichlorobenzylmercapto)acetohydroxamic acid
Code No.: CRL 1) 3,4-Dichlorobenzylthio-acetic acid A mixture of 19.5 (0.1 mol) of 3,4-dichlorobenzylchloride and 7.6 g (0.1 mol) of thiourea in 50 ml of water is heated under reflux for 30 minutes, with stirring, and then, at 6(w700C, a solution of 16 g (0.4 mol) of NaOH in 25 ml of water is run in; the mixture is heated under reflux for 15 minutes and a solution of 15 g (0.15 mol) of chloroacetic acid, 7 g of sodium carbonate and 50 ml of water are run in at 60- 70"C, and the reaction mixture is maintained under reflux for I hour. The mixture is acidified, whilst cold, with concentrated HCI, and is extracted with ether, and the ether extract washed with water, dried and evaporated. The residue is taken up in petroleum ether and the product filtered off. 21 g (yield 83) of the stated product are obtained. Melting point 63--640C.
2) 2-(3,4-Dichlorobenzylmercapto)-acetohydroxamic acid 20.2 g (0.08 mol) of 3,4-dichlorobenzylthioacetic acid are esterified with 10 ml of methanol, 0.6 ml of concentrated H2SO4 and 100 ml of dichloroethane. The mixture is heated under reflux for 4 hours, washed with water and with dilute bicarbonate and dried. The solvent is evaporated in vacuo. The oily residue is treated in methanol with a solution of hydroxylamine (0.1 mol) in the presence of 0.18 mol of sodium methylate. After leaving the reactants in contact overnight, the mixture is evaporated to dryness in vacuo, the residue is taken up in water, the solution is filtered over charcoal and the product is precipitated with 3N HC1, the mixture is extracted with ether, the ether extract is dried, the ether is evaporated and the residue is crystallised from diisopropyl ether. 15 g (yield 71%) of the stated product are obtained; melting point: 75-760C EXAMPLE 8 2-(4-Chlorobenzylmercapto)-propionohydroxamic acid
Code No.: CRL 1) Ethyl 2-(4-chlorobenzylthio)-propionate A mixture of 19.5 ml (0.15 mol) of 4-chlorobenzylmercaptan, 27.1 g (0.15 mol) of ethyl a-bromopropionate, 21 g of potassium carbonate and 0.1 g of potassium iodide in 100 ml of anhydrous acetone is maintained under reflux for 6 hours. The mixture is filtered, the precipitate is washed with acetone and the filtrate is evaporated in vacuo. 200 ml of ether are added to the residue and the ether solution is washed with dilute NaOH, dilute HCI and water. It is then dried and evaporated in vacuo.
2) 2-(4-Chlorobenzylmercapto)-propionohydroxamic acid 10.5 g (0.15 mol) of hydroxylamine hydrochloride are treated with a solution of sodium methylate prepared with 5.75 g (0.25 gram atom) of sodium in 200 ml of methanol. The sodium chloride is filtered off and 25.85 g (0.1 mol) of ethyl 2-(pchlorobenzylthio)-propionate are added to the filtrate. After leaving the reactants in contact overnight, the mixture is evaporated in vacuo, the residue is taken up with 200 ml of water, the solution is filtered and the product precipitated with 3N HCI, filtered off, washed with water and dried; 20.2 g (yield; 82%) of the stated hydroxamic acid are obtained. Melting point: 104--1050C.
EXAMPLE 9 a-Naphthylmethylenemercapto-acetohydroxamic acid Code No.: CRL
1) a-Naphthylmethylene-thioacetic acid A solution of 15.2 g (0.2 mol) of thiourea in 100 ml of water is introduced into a 1 litre three-necked flask equipped with a magnetic stirrer, a condenser and a dropping funnel, and 35.3 g (0.2 mol) of a-chloromethyl-naphthalene are added, all at once, at 50--600C. The reaction mixture is heated to the reflux temperature and boiling is maintained for a quarter of an hour. The thiouronium salt precipitates.
Thereafter the mixture is cooled and a solution of 32 g of sodium hydroxide (0.8 mol) in 50 ml of water is added dropwise at about 60"C. The resulting mixture is heated under reflux until the solution becomes limpid, and is cooled and a solution of about 0.28 mol of sodium chloroacetate (obtained by neutralising 26.36 g of chloroacetic. acid in 200 ml of water with 23.52 g of sodium bicarbonate) is added dropwise at 60--700C. The whole is then heated under reflux for half an hour, cooled and acidified cold by the addition of 3N HCI. s4-Naphthylmethylene- thioacetic acid thus precipitates, and is filtered off. 44.5 g of product are collected.
(Yield: 95%). Instantaneous melting point: 102--1030C.
2) Ethyl a-naphthylmethylene-thioacetate 19.72 g (0.085 mol) of the above product are dissolved in 160 ml of 1,2dichloroethane and 16 ml of anhydrous ethanol and 1.6 ml of concentrated sulphuric acid are added. The mixture is heated under reflux for at least 2 hours and cooled, the organic phase is decanted and the water formed discarded. The organic phase is washed with a dilute solution of sodium hydroxide and then with water. It is then dried over MgSO4 and the solvent is evaporated. 19.8 g of ethyl a- naphthylmethylene-thioacetate [overall yield: 890/,] are thus obtained, this product being in the form of a limpid orange-coloured oil.
3) a-Naphthylmethylenemercapto-acetohydroxamic acid The ester obtained above (0.076 mol), diluted with 50 ml of methanol, is added to a solution of hydroxylamine, prepared from 7.92 g (0.114 mol) of hydroxylamine hydrochloride in 190 ml of methanol and 4.37 g (0.19 gram atom) of sodium in 190 ml of anhydrous methanol. After leaving the reactants in contact overnight at 20"C, the methanol is evaporated, the residue is taken up in water (alkaline medium), the mixture is filtered over charcoal and acidified by adding 3N HCI, and a - naphthylmethylene - thio - acetohydroxamic acid is thus precipitated; it is filtered off, washed with water and then with ether, and dried, 11.2 g (0.0453 mol) of the product (overall yield: 59%) are collected after recrystallisation from ethyl acetate. Instantaneous melting point: 129--1300C.
EXAMPLE 10 2-(4-Fluorobenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) p-Fluorobenzylthioacetic acid A solution of 15.2 g (0.2 mol) of thiourea in 100 ml of water is introduced into a 1 litre three-necked flask equipped with a magnetic stirrer, a condenser and a dropping funnel, and 28.9 g (0.2 mol) of p-fluorobenzyl chloride are added all at once, at 5600C. The mixture is heated to reflux temperature, boiling is maintained for about 15 minutes and the solution becomes limpid. Thereafter the solution is cooled and a solution of 32 g (0.8 mol) of NaOH in water is added dropwise at about 60"C. The whole is heated under reflux for about 30 minutes, the mixture is cooled and a solution of about 0.28 mol of sodium chloroacetate (obtained by neutralising 26.46 g of chloroacetic acid in 200 ml of water with 23.52 g of sodium bicarbonate) is added drdpwise at 60--700C. Thereafter the whole is heated under reflux for 30 minutes and then cooled. The mixture is acidified with 3H HC1 and the oil which is obtained is taken up in methylene chloride, this mixture is washed with a dilute sodium bicarbonate solution, filtered over charcoal and acidified once more with 3N HCI; p-fluorobenzylthioacetic acid is thus precipitated, and is filtered off. After recrystallising from cyclohexane, 33.4 g (yield: 83%) of the said acid are collected. Instantaneous melting point: 68--69"C.
2) Ethyl p-fluorobenzylthioacetate 17 g (0.085 mol) of the acid obtained above are dissolved in 160 ml of 1,2 dichloroethane and 16 ml of anhydrous methanol and 1.6 ml of concentrated H2SO4 are added. The whole is heated under reflux for about 6 hours and then cooled, the organic phase is decanted and the water which forms is discarded, and the organic phase is washed with a dilute sodium bicarbonate solution and then with water. The solution is then dried over Na2SO4 and the solvent evaporated. 17.4 g of a yellow oil are thus collected; this is ethyl p-fluorobenzylthioacetate (overall yield: 89).
3) 2-(4-Fluorobenzylmercapto)-acetohydroxamic acid The ester obtained above (0.0763 mol) is added to a solution of hydroxylamine prepared from 7.92 g (0.114 mol) of hydroxylamine hydrochloride in 190 ml of methanol and 4.37 g of sodium in 190 ml of anhydrous methanol. After leaving the reactants in contact overnight at ambient temperature, the methanol is evaporated, the residue is taken up in water, the solution is filtered over charcoal and acidified with 3N HCI and 2 -(4 - fluorobenzylmercapto) - acetohydroxamic acid is thus precipitated; it is filtered off and washed with water. 11.2 g (yield: 680/,) of the said acid are collected. Instantaneous melting point: 115--1160C.
EXAMPLE 11 2-(4-Methoxybenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) p-Methoxybenzylthio-acetic acid A solution of 18.24 g (0.24 mol) of thiourea in 104 ml of 48% strength hydrobromic acid and 20 ml of water is introduced into a 1 litre three-necked flask equipped with a magnetic stirrer and a condenser. The mixture is heated at 600C and 27.6 g (0.2 mol) of p-methoxybenzyl alcohol are introduced. The temperature is raised to 950C and the mixture is allowed to cool. Crystals of the thiouronium salt appear; these are filtered off and dried. The precipitate obtained above is introduced into a 500 ml three-necked flask with 60 ml of NaOH. The mixture is heated to 700C and a solution of 15.6 g (0.164 mol) of chloroacetic acid dissolved in 30 ml of water is added dropwise. Thereafter the whole is heated under reflux for half an hour and then cooled. The mixture is acidified with 3N HCI, the oil obtained is taken up in methylene chloride, and the mixture is washed with a dilute sodium bicarbonate solution, filtered over charcoal, and acidified once more with 3N HCI in order to precipitate p-methoxybenzylthio-acetic acid. 25.7 g (yield 60%) of the said acid are collected (melting point 600 C).
2) Ethyl p-methoxybenzylthio-acetate 24 g (0.112 mol) of the acid obtained above are dissolved in 210 ml of 1,2dichloroethane and 22 ml of anhydrous ethanol and 2.2 ml of concentrated sulphuric acid are added. The whole is heated under reflux for about 6 hours, cooled, the organic phase is decanted and the water which forms discarded, and the organic phase is washed with a dilute bicarbonate solution and then with water.
The solution is then dried over Na2SO4 and the solvent evaporated. 26.5 g of a limpid yellow oil are thus collected; this is ethyl p-methoxybenzylthio-acetate (overall yield: 96%).
3) 2-(4-Methoxybenzylmercapto)-acetohydroxamic acid The above product (0.110 mol), diluted in 50 ml of methanol, is added to a solution of hydroxylamine prepared from 11.63 g (0.165 mol) of hydroxylamine hydrochloride in 275 ml of methanol and 6.32 g of sodium in 275 ml of anhydrous methanol. After leaving the reactants in contact overnight at ambient temperature,
EXAMPLE 12 2-(2,4-Dichlorobenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) 2,4-Dichlorobenzylthio-acetic acid 15.2 g (0.2 mol) of thiourea in 100 ml of water are introduced into a 1 litre three-necked flask. The mixture is heated at 50--600C and 39.1 g (0.2 mol) of 2,4 dichlorobenzyl chloride are added all at once. The mixture is heated to reflux and boiling is maintained for 15 minutes; the solution becomes limpid. It is then cooled and a solution of 32 g (0.8 mol) of NaOH in 50 ml of water is added dropwise at about 60"C. The mixture is again heated under reflux for 30 minutes, cooled and a solution of about 0.28 mol of sodium chloroacetate (obtained by neutralising 26.46 g of chloroacetic acid in 200 ml of water with 23.52 g of NaHCO3) is added dropwise at 60--700C. Thereafter the whole is heated under reflux for 30 minutes, cooled, filtered and acidified with 3N HCI; the precipitate obtained is filtered off and redissolved whilst cold in dilute bicarbonate solution, and this solution is washed with methylene chloride, filtered and acidified once more. 41.7 g (yield 83%) of the product are thus collected. Instantaneous melting point 72--73"C.
2) Ethyl 2,4-dichlorobenzylthio-acetate 37.65 g (0.15 mol) of the above acid are dissolved in 283 ml of 1,2dichloroethane and 28.5 ml of anhydrous ethanol and 2.9 ml of concentrated H2SO4 are added. The whole is heated under reflux for 6 hours and then cooled, the organic phase is decanted and the water which forms discarded, and the organic phase is washed with a dilute bicarbonate solution and then with water. Thereafter the solution is dried over Na2SO4 and the solvent evaporated. 43.6 g of a yellow oil are thus collected: this is ethyl 2,4 - dichlorobenzylthio - acetate (overall yield: 90%).
3) 2-(2,4-Dichlorobenzylmercapto)-acetohydroxamic acid The above ester (0.156 mol) is added to a solution of hydroxylamine prepared from 16.38 g (0.235 mol) of hydroxylamine hydrochloride in 300 ml of methanol and 9 g (0.391 gram atom) of sodium in 300 ml of anhydrous methanol. After leaving the reactants in contact overnight at ambient temperature, the methanol is evaporated, the residue is taken up in water, and the solution is filtered over charcoal and acidified with 3N HCI in order to precipitate 2 - (2,4 - dichlorobenzylmercapto) acetohydroxamic acid, which is filtered off and washed with water. 28 g (yield: 67%) of the said acid are collected. Instantaneous melting point: 116"C.
EXAMPLE 13 2-(2,6-Dichlorobenzylmercapto)-acetohydroxamic acid
Code No.: CRL On carrying out the process as indicated in Example 12, but replacing the 2,4 (Cl2)C6H3CH2CI with 2,6-(CI2)C6H3CH2CI, there are obtained successively: 1) 2,6 - dichlorobenzylthio - acetic acid (yield 83; instantaneous melting point: 81-820C), 2) ethyl 2,6 - dichlorobenzylthio - acetate (yield 89%)which is in the form of a yellow oil, and 3) 2 - (2,6 - dichlorobenzylmercapto) - acetohydroxamic acid (yield 71; instantaneous melting point: 124 C).
EXAMPLE 14 2-(4-Nitrobenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) Ethyl 4-nitrobenzylthioacetate 43.2 g (0.2 mol) of p-nitrobenzyl bromide, 200 ml of acetone, 0.2 g of potassium iodide, 24 ml of ethyl thioglycollate (that is to say a slight excess) and 27.6 g (0.2 mol) of potassium carbonate are introduced successively into a 1 litre three-necked flask. The mixture is heated under reflux for about 4 hours until the complete disappearance of the bromo derivative; the acetone is evaporated, the oil obtained is taken up in ether and in water, the ether phase is washed with a dilute NaOH solution, so as to eliminate the excess thiol, and then with a dilute HCI solution, and is dried over Na2SO4, and the solvent is evaporated. 49 g (yield: g5%) of the stated product are obtained, which is in the form of an orange-coloured oil.
2) 2-(4-Nitrobenzylmercapto)-acetohydroxamic acid The above ester (0.156 mol), diluted in 50 ml of methanol, is added to a solution of hydroxylamine prepared from 16.38 g (0.235 mol) of hydroxylamine hydrochloride in 300 ml of methanol and 9 g (0.391 gram atom) of sodium in 300 ml of anhydrous methanol. The reactants are left in contact overnight at ambient temperature, the sodium chloride formed is filtered off, the reaction mixture is acidified immediately, the solvent is evaporated, and the precipitate obtained is taken up in water and filtered off. After recrystallisation from isopropyl alcohol, 27 g of 2- (4 - nitrobenzylmercapto) - acetohydroxamic acid are obtained.
Instantaneous melting point: 118--1190C; yield: 72%.
EXAMPLE 15 2-(3 ,4-Methylenedioxybenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) 3,4-Methylenedioxybenzylthio-acetic acid A solution of 18.24 g (0.24 mol) of thiourea in 104 ml of 48 strength hydrobromic acid and 20 ml of water is introduced into a one litre three-necked flask equipped with a magnetic stirrer and a condenser. The mixture is heated to 60"C and 30.4 g (0.2 mol) of piperonyl alcohol are introduced. The temperature is raised to 95"C and the mixture is left to cool. Crystals of the thiouronium salt appear; these are filtered off and dried. The precipitate thus obtained is introduced into a 500 ml three-necked flask with 60 ml of sodium hydroxide solution. The mixture is heated to 700C and 15.6 g (0.164 mol) of chloroacetic acid in 30 ml of water are added dropwise. Thereafter the whole is heated under reflux for half an hour and then cooled. The mixture is acidified with 3N HC1, the precipitate obtained is redissolved in a dilute bicarbonate solution, and the solution is washed with methylene chloride, filtered over charcoal and acidified once more with 3N HCI in order to precipitate 3,4-methylenedioxybenzylthio-acetic acid, which is filtered off. After recrystallisation from a diisopropyl ether/petroleum ether mixture (1:1 v/v), 18.2 g (yield 40%) of the said acid are collected (instantaneous melting point: 87"C).
2) Ethyl 3,4-methylenedioxybenzylthio-acetate 18.08 g (0.08 mol) of the above acid are dissolved in 160 ml of 1,2 dichloroethane and 16 ml of anhydrous ethanol and 1.6 ml of concentrated H2SO4 are added. The whole is heated under reflux for about 6 hours, cooled, the organic phase decanted and the water which forms discarded, and the organic phase is washed with a dilute bicarbonate solution and then with water. Thereafter the solution is dried over Na2SO4 and the solvent evaporated. 21 g of an orangecoloured oil are obtained: this is ethyl 3,4-methylenedioxybenzylthio-acetate (yield: 96%).
3) 2-(3 ,4-Methylenedioxybenzylmercapto)-acetohydroxamic acid The above product (0.085 mol) is added to a solution of hydroxylamine prepared from 8.76 g (0.126 mol) of hydroxylamine hydrochloride in 210 ml of methanol and 4.83 g (0.21 gram atom) of sodium in 210 ml of anhydrous methanol.
The reactants are left in contact overnight at ambient temperature, the methanol is evaporated, the residue is taken up in water, the solution is filtered over charcoal and acidified with 3N HC1, and the precipitate obtained is filtered off and washed with water. 14.5 g (yield: 70%) of 2 - (3,4 - methylenedioxybenzylmercapto) acetohydroxamic acid are obtained. Instantaneous melting point: 127--128"C, (yield: 70%).
EXAMPLE 16 2-(3,4-Dimethoxybenzylmercapto)-acetohydroxamic acid
Code No.: CRL 1) 3,4-Dimethoxybenzylthio-acetic acid 13.07 g (0.172 mol) of thiourea and 86 ml of water are charged into a 1 litre three-necked flask equipped with a magnetic stirrer and a condenser. The mixture is heated to 50--600C and 32 g (0.172 mol) of 3,4-dimethoxybenzyl chloride are added all at once. The mixture is heated under reflux and boiling is maintained for 15 minutes; the solution becomes limpid. Thereafter the solution is cooled and a solution of 27.52 g (0.688 mol) of NaOH in 43 ml of water is added dropwise at about 60"C. The mixture is again heated under reflux for 30 minutes, cooled and a solution of sodium chloroacetate (obtained by neutralising 22.76 g of chloroacetic acid in 172 ml of water with 20.23 g of NaRCO3) is added dropwise at 60---700C.
Thereafter the whole is heated under reflux for 30 minutes, cooled and filtered and the filtrate then acidified with 3N HCI. After recrystallisation from toluene, 28.7 g of 3,4 - dimethoxybenzylthio - acetic acid are obtained. Yield: 69%. Instantaneous melting point: 94"C.
2) Methyl 3,4-dimethoxybenzylthio-acetate 24.2 g (0.1 mol) of the above acid are dissolved in 200 ml of anhydrous methanol and 4 ml of concentrated sulphuric acid are added. The whole is heated under reflux for about 3 hours, the methanol is evaporated and the oil which is obtained is taken up in ether, the organic phase is washed with a dilute sodium bicarbonate solution and then with water and dried over Na2SO4, and the solvent evaporated. 24.2 g (yield: 94%) of the stated product, which is in the form of an orange-coloured oil, are thus collected.
3) 2-(3,4-Dimethoxybenzylmercapto)-acetohydroxamic acid The above product (0.0945 mol) is added to a solution of hydroxylamine prepared from 9.95 g (0.143 mol) of hydroxylamine hydrochloride in 200 ml of methanol and from 5.45 g (0.237 gram atom) of sodium in 200 ml of anhydrous methanol. The reactants are left in contact overnight at ambient temperature, the mixture is filtered, the methanol is evaporated, the residue is taken up in water, the solution is filtered over charcoal and acidified with 3N HCI, the oil obtained is taken up in methylene chloride, the solution is dried over Na2SO4, the solvent is evaporated and the residue is taken up in ethyl acetate. After filtration and washing with ether, 16.9 g (yield 70%) of the stated product are obtained. Instantaneous melting point: 780C.
EXAMPLE 17 2-(2,6-Dimethyl-anilino)-acetamidoxime hydrochloride
Code No.: CRL 40,492 1) Benzenesulfphonate-acetonitrile (C5H5SO3-CH2CN) 104 g (1.6 mols) of potassium cyanide are dissolved in 100 ml of water. 160 g (1.6 mols) of a 30% strength formaldehyde solution are introduced at between 5 and 10"C. The mixture is stirred for 30 minutes. 212 g (1.2 mols) of benzenesulphonyl chloride are introduced dropwise at a temperature of between 10 and 20"C. The mixture is stirred at this temperature for 6 hours. The product is extracted with benzene. The benzene is washed with water. The benzene phase is decanted.
Traces of water are removed by distilling the C6H6. H2O azeotrope. The benzene is evaporated to dryness and the residue is distilled in vacuo.
Weight: 158.5 g Yield: 67% Melting point: 32--34"C Density: 1.3089 NDO 1.5252 Boiling point 5 mm HD: 165--170"C.
2) 2-(2,6-Dimethyl-anilino)-acetonitrile A solution of 158.5 g (0.804 mol) of benzene-sulphonate-acetonitrile in 200 ml of ethyl acetate is run dropwise into a solution of 193.6 g (1.608 mols) of 2,6 zdimethyl-aniline in 400 ml of ethyl acetate. The mixture is heated under reflux for 3 hours, cooled and the excess aniline benzenesulphonate is filtered off. The filtrate is evaporated to dryness. The residue is taken up in ether. Insoluble material is again filtered off and discarded. The ether is evaporated to dryness. The residue is taken up in a mixture of petroleum ether/benzene (3:4 v/v). The crystals which form are filtered off.
Weight: 84.2 g.
Yield: 65%.
3) CRL 40,492 84.2 g (0.526 mol) of the above nitrile are dissolved in methanol and this solution is run into a solution of 2.4 mols of hydroxylamine base in methanol (this solution of hydroxylamine base having been obtained by running a solution of 129.6 g (2.4 mols) of sodium methylate in 500 ml of methanol into a solution of 166.8 g (2.4 mols) of hydroxylamine hydrochloride in 1 litre of methanol and filtering off the NaCI formed).
The mixture is stirred overnight at ambient temperature (15-250C). 300 ml of water are added to the reaction mixture and the methanol is evaporated. The pH of the residual aqueous phase is adjusted to 11 with K2CO3 and the alkaline phase is extracted with ethyl acetate. The ethyl acetate is washed with 3 times 200 ml of water. The solvent is dried over MgSO4 in the presence of 3 SA charcoal. The amidoxime hydrochloride is precipitated with 150 ml of a 7N hydrogen chloride solution in ethanol. The crystals are filtered off and recrystallised from an acetone/ethanol mixture in order to obtain CRL 40,492.
Weight: 32 g Yield: 26.4% Melting point: 1840C (with decomposition) Measured % Cl-: 15.44% Theoretical C1-: 15.46%.
The purity of CRL 40,492 is controlled by thin layer chromatography [eluant: C6H6/CH3COCH3/NH4OH (30:70:2 v/v); plate:silica gel (Merck F 254); development:U.V.+Draggendorf reagent].
EXAMPLE 18 2-(3-Chloro-anilino)-acetamidoxime hydrochloride
Code No.: CRL 40,427 The procedure followed is as indicated in Example 13 of the main application (synthesis of CRL 40,375), replacing the 3,4-dichloro-aniline with 3-chloro-aniline.
4.2 g (yield: 4.4%) of CRL 40,427 are obtained.
Melting point: 134"C.
Analysis shows that the product obtained according to this method contains traces of 2 - (3 - chloro - anilino) - acetamidoxime dihydrochloride, since the chlorine percentages are as follows: Measured % Cl-=16.37% Theoretical % C1-=15.04%.
EXAMPLE 19 2-(4-Methylanilino)-acetamidoxime dihydrochloride
Code No. CRL 40,457 0.105 Mol of 2 - (4 - methylanilino) - acetonitrile in solution in methanol are treated with a solution of hydroxylamine base in methanol prepared as indicated above. The reactants are left in contact overnight at ambient temperature. Thin layer chromatography [eluant:toluene/acetone/NH40H (30:70:2 v/v); plate:silica gel (Merck F 254); development:U.V.+Draggendorf reagent] makes it possible to demonstrate the disappearance of the nitrile and the appearance of the amidoxime.
100 ml of water are added to the reaction mixture and the methanol is evaporated. The base is extracted with ethyl acetate. The ethyl acetate is washed with water, dried over MgSO4 in the presence of 3 SA charcoal and filtered. The dihydrochloride is precipitated with a hydrogen chloride solution in ethanol. CRL 40,457 is obtained by recrystallisation from an acetone/ethanol mixture (1:1 v/v).
Weight: 5.65 g Yield: 22% Melting point: 172"C Measured% Cl-: 28.42% Theoretical % Cl-: 28.17%.
EXAMPLE 20 2-(3-Methylanilino)-acetamidoxime dihydrochloride
Code No.: CRL 40,477 The procedure followed is as indicated in Example 19, replacing the 2 - (4 methylanilino) - acetonitrile with 0.105 mol of 2- (3 - methylanilino)acetonitrile. CRL 40,477 is obtained by recrystallisation from an ethyl acetate/ethanol mixture (the recrystallisation is aided by the addition of petroleum ether to the ethyl acetate/ethanol mixture).
Weight: 12 g Yield: 15% Melting point: 150 C Measured % Cl-: 27.80 /,, Theoretical /" Cl-: 27.77%.
EXAMPLE 21 2-(2-Fluoroanilino)-acetamidoxime hydrochloride
Code No.: CRL 40,478 A solution of 59.1 g of benzenesulphonate-acetonitrile is run into a solution of 66.6 g (0.6 mol) of 2-fluoroaniline in 300 ml of ethyl acetate. The mixture is heated under reflux for 3 hours. The insoluble matter (2-fluoroaniline benzenesulphonate) is filtered off and the ethyl acetate is evaporated. The resulting residue is treated with a solution of 0.6 mol of hydroxylamine base in methanol, prepared as indicated above.
The mixture is allowed to stand overnight at ambient temperature (l5-250C).
100 ml of water are added and that methanol is evaporated. The aqueous phase is extracted with ethyl acetate. The solvent is washed with water, decanted, and is dried over MgSO4 in the presence of 3 SA charcoal. The insoluble matter is filtered off. The hydrochloride is precipitated with a solution of hydrogen chloride in ethanol. The crystals are recrystallised from an ethyl acetate/ethanol mixture using petroleum ether to facilitate the crystallisation. CRL 40,478 is thus obtained.
Weight: 5 g Yield: 7.5%- Melting point: 170 C Measured % Cl-: 16.54% Theoretical C1-: 16.17%.
The purity can be checked by thin layer chromatography [eluant:toluene/acetone/NH4OH (30:70:2 v/v); plate:silica gel (Merck F 254); development:U.V.+Draggendorf reagent].
EXAMPLE 22 2-(4-Methoxyanilino)-acetamidoxime dihydrochloride
Code No.: CRL 40,482 The procedure is followed as indicated in Example 21, replacing the 2fluoroaniline with 0.2 mol of 4-methoxyaniline. CRL 40,482 is thus obtained.
Weight: 5 g Yield: 20% Melting point: 154 C Measured % Cl-: 26.04% Theoretical % Cl-: 26.49%.
The purity can be checked by thin layer chromatography [eluant:benzene/acetone/NH4OH (30:70:2 v/v); plate:silica gel (Merck F 254); development:U.V.+Draggendorf reagent].
EXAMPLE 23 2-(2-Methoxy-anilino)-acetamidoxime dihydrochloride
Code No.: CRL 40.483 The procedure followed is as indicated in Example 21, replacing the 2-fluoroaniline with 2-methoxy-aniline. 4.5 g (yield: 10%) of CRL 40,483 are obtained by recrystallisation from an acetone/ethanol mixture (1:1 v/v).
The purity can be checked as indicated in Example 22.
EXAMPLE 24 2-(2-Chloroanilino)-acetamidoxime hydrochloride
Code No.: CRL 40,487 The procedure followed is as indicated in Example 21, replacing the 2-fluoroaniline with 2-chloro-aniline. 5 g (yield: 10%) of CRL 40,487 are thus obtained.
The purity can be checked as indicated in Example 22.
The pharmacological tests which have been carried out with the compounds according to the invention have made it possible to show their action on the central nervous system. More precisely, the compounds of the invention are sedatives, anxiolytic agents and/or muscular relaxants. Moreover, CRL 40,522 (the product of Example 4) exhibits, in addition to these actions on the central nervous system, a hypotensive effect at a dose of 50 mg/kg (administered orally in aqueous solution at a concentration of 5 g/l of CRL 40,522) in genetically hypertensive rats. The reduction in arterial pressure is about 17% and the hypotensive effect disappears 24 hours after administration of the product.
The compounds are thus indicated for treatment of neuropsychic ailments.

Claims (27)

WHAT WE CLAIM IS:
1. 2-(2-Methylanilino) acetamidoxime and its acid addition salts.
2. 2-(4-Fluoroanilino) acetamidoxime and its acid addition salts.
3. 2-(2-Bromoanilino) acetamidoxime and its acid addition salts.
4. 2-(3,4-Dichloroanilino) acetamidoxime and its acid addition salts.
5. 2-(4-Chlorobenzylmercapto)acetamidoxime and its acid addition salts.
6. 2-(4-Chlorobenzylmercapto)acetohydroxamic acid and its metal salts.
7. 2-(3,4-Dichlorobenzylmercapto)acetohydroxamic acid and its metal salts.
8. 2-(4-Chlorobenzylmercapto)propionhydroxamic acid and its metal salts.
9. a-Naphthylmethylenemercaptoacetohydroxamic acid and its metal salts.
10. 2-(4-Fluorobenzylmercapto)acetohydroxamic acid and its metal salts.
11. 2-(4-Methoxybenzylmercapto)acetohydroxamic acid and its metal salts.
12. 2-(2,4-Dichlorobenzylmercapto)acetohydroxamic and its metal salts.
13. 2-(2,6-Dichlorobenzylmercapto)acetohydroxamic acid and its metal salts.
14. 2-(4-Nitrobenzylmercaptoacetohydroxamic acid and its metal salts.
15. 2-(3,4-Methylenedioxybenzylmercapto)acetohydroxamic acid and its metal salts.
16. 2-(3,4-Dimethoxybenzylmercapto)acetohydroxamic acid and its metal salts.
17. 2-(2,6-Dimethylanilo)acetamidoxime and its acid addition salts.
18. 2-(3-Chloroanilino)acetamidoxime and its acid addition salts.
19. 2-(4-Methylanilino)acetamidoxime and its acid addition salts.
20. 2-(3-Methylanilino)acetamidoxime and its acid addition salts.
21. 2-(2-Fluoroanilino)acetamidoxime and its acid addition salts.
22. 2-(4-Methoxyanilino)acetamidoxime and its acid addition salts.
23. 2-(2-Methoxyanilino)acetamidoxime and its adid addition salts.
24. 2-(2-Chloroanilino)acetamidoxime and its acid addition salts.
25. Compounds according to any one of claims 1, 2, 4, 5, 6, 17, 18, 21 and 24 in the form of hydrochlorides.
26. Compounds according to any one of claims 19, 20, 22 and 23 in the form of dihydrochlorides.
27. A therapeutic composition comprising a compound according to any one of claims I to 26 in association with a physiologically acceptable excipient.
GB1670577A 1976-01-26 1977-04-21 Phenylamidine derivatives Expired GB1588533A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB1670577A GB1588533A (en) 1977-04-21 1977-04-21 Phenylamidine derivatives
CH118978A CH630606A5 (en) 1977-02-15 1978-02-03 Phenylamidine derivatives useful especially in therapeutics
DE19782804576 DE2804576A1 (en) 1977-02-15 1978-02-03 PHENYLAMIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREOF
ES466887A ES466887A2 (en) 1977-01-24 1978-02-10 A procedure for the preparation of a substitute phenylamidine. (Machine-translation by Google Translate, not legally binding)
CA296,767A CA1133920A (en) 1977-02-15 1978-02-10 Phenylamidine derivatives
FR7804019A FR2380256A2 (en) 1976-01-26 1978-02-13 Phenyl aceto-hydroxamic acids and amidoxime(s) - used as sedatives, anxiolytics, muscle relaxants and hypotensives
BE185158A BE863947R (en) 1977-02-15 1978-02-14 SUBSTITUTED PHENYL-AMIDINES
IT67297/78A IT1156441B (en) 1977-02-15 1978-02-14 PROCEDURE FOR THE PREPARATION OF FENYL AMMIDINE DERIVATIVES
JP1639078A JPS53103430A (en) 1977-02-15 1978-02-14 Phenylamidine derivatives
US06/107,609 US4325964A (en) 1977-02-15 1979-12-27 Phenylamidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1670577A GB1588533A (en) 1977-04-21 1977-04-21 Phenylamidine derivatives

Publications (1)

Publication Number Publication Date
GB1588533A true GB1588533A (en) 1981-04-23

Family

ID=10082185

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1670577A Expired GB1588533A (en) 1976-01-26 1977-04-21 Phenylamidine derivatives

Country Status (1)

Country Link
GB (1) GB1588533A (en)

Similar Documents

Publication Publication Date Title
US4670566A (en) 3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
US4440785A (en) Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation
CA2036304C (en) Pyrimidinedione derivatives, their production and use
AU680037B2 (en) Piperazine derivatives as alpha1a-adrenergic receptor antagonists
US4146647A (en) Substituted phenyl-amidines
US5589477A (en) Pyrimidine derivatives and drugs
PL148590B1 (en) Method of obtaining novel derivatives of 2-amino-5-hydroxy-4-methylpyrimidine
EP0674627A1 (en) Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
BG62023B2 (en) Tetrahydrobenzthiazoles, method for their preparation and application as intermediate products or medicamentous forms
NZ212856A (en) Glutarimide derivatives and pharmaceutical compositions
PL188012B1 (en) Benzamidine derivatives and their application an therapeutic agents being antagonists in respect to ltb-4
US4405635A (en) 4-Aroylimidazol-2-ones and their use as pharmaceuticals
IE58394B1 (en) New substituted bis-(4-aminophenyl)-sulfones, the preparation thereof and their use as pharmaceutical compositions
SK19272001A3 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
US4325964A (en) Phenylamidine derivatives
US3632605A (en) Pyrroline derivatives
HU211517A9 (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
US4100286A (en) 2-(Substituted heterocyclic amine)benzoic acids
AU2002254911B2 (en) Bicyclic guanidine derivatives and therapeutics uses thereof
GB1588533A (en) Phenylamidine derivatives
PL139815B1 (en) Method of obtaining novel 2-amino-3-/halogenobenzoilo/-methylphenylacetic acids in the form of salts
CS229692B2 (en) Manufacturing process of derivate 4-phenylquinazoline
US4581349A (en) Certain benzodiimidazoles and their use as radiation sensitizers
AU2002254911A1 (en) Bicyclic guanidine derivatives and therapeutics uses thereof
EP0089426B1 (en) 2-amino-6-biphenylacetic acids

Legal Events

Date Code Title Description
PS Patent sealed
746 Register noted 'licences of right' (sect. 46/1977)